Skin of Color
The latest on diagnosis and management
Joel Schlessinger, MD, FAAD
A review of the benefits of having a formal training program.
Easing of guidelines may allow more practices to add teleconsults.
Mark D. Kaufmann, MD, FAAD
Understand why backlinks matter. And how to get them.
Things to do now to prepare.
David B. Mandell, JD, MBA, and Carole Foos, CPA
A look at current tools for risk stratification of melanoma, controversy surrounding SLNB for staging, and novel adjuvant immunotherapies for early stage disease.
Megan H. Trager, and Larisa J. Geskin, MD
While Mohs surgery boasts the highest cure rates for NMSC, dermatologists should be up to date on all options, including SRT.
Kristine A. Romine, MD
Gary Goldenberg, MD, FAAD
Désirée Ratner, MD
Ten strategies to consider, even if your office is closed or your staff are furloughed.
Kasey D’Amato, PA-C
A number of drugs in development show promise for one of the most challening skin diseases.
Donovan G. Kearns, BS; Shelley K. Uppal, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD
CSF Faculty share experiences and tips for practicing in the “new normal.”
Trifarotene is the first novel topical retinoid approved for the treatment of facial and truncal acne in 20 years.
Joshua Zeichner, MD
DeAnna Diaz, MS, MBS, OMS-III, and Chérie M. Ditre, MD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.